Vector Remote

AUGUST 8, 2022

What Clinics Can Do to Protect the Diagnosis and Treatment of Cardiac Arrhythmias Scope of Reimbursement Cuts The release of the annual Proposed Medicare Physician Fee Schedule is an event that business leaders and caregivers in healthcare anxiously anticipate.

Reimbursement 52

Reimbursement Electrophysiology Medicare Arrhythmia 52

DAIC

JUNE 11, 2024

In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

Cardiomatics

JULY 14, 2022

These complications include new-onset arrhythmias, which are also common in stroke patients who have not experienced heart disease before. For post-stroke patients, arrhythmias represent a key risk factor for complications and a worse prognosis. Cardiac complications frequently follow acute stroke. It has provided top quality analyses.”

Arrhythmia 52

Arrhythmia Stroke Strokes Reimbursement 52

CardiacWire

DECEMBER 3, 2023

Jimenez and Ali co-founded AccurKardia in 2019 with a vision for unlocking the value of the ECG signal, and the company currently markets one of the few FDA-cleared solutions for automated ECG interpretation and arrhythmia detection. Here’s the rest of their story and vision for ECG automation.

Arrhythmia 52

Arrhythmia Atrial Flutter Reimbursement Atrial Fibrillation 52

Vector Remote

MARCH 9, 2023

Cardiac devices managed by RPM software are reducing hospital admissions and time to diagnosis and treatment for patients with arrhythmias and heart failure. What’s Next in Cardiac Remote Patient Monitoring Software ?

Heart Failure 52

Heart Failure Patient Care Heart Rhythm Hypertension 52

DAIC

JUNE 19, 2024

Inevitably, given its fledgling status, regulation and reimbursement is still playing catch-up, though 2023 saw some important developments in this regard. By 1909 ECGs were being used to diagnose cases of arrhythmia; by 1910 to diagnose indicators of a heart attack.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

DAIC

MARCH 7, 2024

The cohort receiving the lowest dose of 20 million cells has been initiated with no treatment-emergent adverse events, arrhythmias, rejection, or allergic response. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement. The first author of the study is R.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105